Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
+9.3M
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$120M
-
Put/Call ratio
-
0.43
-
Number of buys
-
185
-
Number of sells
-
-120
-
Price
-
$11.58
Significant Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q2 2025
352 filings reported holding TXG - 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share as of Q2 2025.
10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
.
Largest 10 shareholders include ARK Investment Management LLC (13.9M shares), VANGUARD GROUP INC (12.4M shares), BlackRock, Inc. (9.43M shares), FMR LLC (9M shares), Sumitomo Mitsui Trust Group, Inc. (6.02M shares), Nikko Asset Management Americas, Inc. (6.01M shares), AQR CAPITAL MANAGEMENT LLC (4.14M shares), MORGAN STANLEY (3.49M shares), BANK OF AMERICA CORP /DE/ (3.02M shares), and MILLENNIUM MANAGEMENT LLC (2.88M shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.